North America Vet Compounding Pharmacies Market

Table of Content

1. Executive Summary

    1.1. North America Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Adoption Rate/Usage Analysis - Key Statistics

    4.2. Value Chain Analysis

    4.3. Regulatory Scenario

    4.4. Product USP Analysis

    4.5. PESTEL Analysis

    4.6. Porter’s Analysis

    4.7. Key Promotional Strategies, By Key Players

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. North America GDP Growth Outlook

        5.1.2. North America Healthcare Outlook

        5.1.3. Global Compounding Pharmacies Market Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Product Adoption Rate

        5.2.2. Prevalence of Chronic Diseases

        5.2.3. Strategic Collaborations

        5.2.4. Rising Pet Adoption

        5.2.5. Cost of Product

        5.2.6. Treatment Regime

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

    6.1. COVID-19 and Impact Analysis

        6.1.1. By Product

        6.1.2. By Animal Type

        6.1.3. By Formulations

        6.1.4. By Country

    6.2. 2022 Market Scenario

7. North America Vet Compounding Pharmacies Market Demand (in Value US$ Mn) Analysis 2014-2022 and Forecast, 2023-2033

    7.1. Historical Market Value (US$ Mn) Analysis, 2014-2022

    7.2. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. North America Vet Compounding Pharmacies Market Analysis 2014-2022 and Forecast 2023-2033, By Product

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis, by Product, 2014-2022

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Product, 2023-2033

        8.3.1. CNS Agents

        8.3.2. Anti-Infective Agents

        8.3.3. Hormones and Substitutes

        8.3.4. Anti-inflammatory Agents

        8.3.5. Others

    8.4. Market Attractiveness Analysis, by Product

9. North America Vet Compounding Pharmacies Market Analysis 2014-2022 and Forecast 2023-2033, By Animal Type

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis, by Animal Type, 2014-2022

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Animal Type, 2023-2033

        9.3.1. Companion Animals

            9.3.1.1. Dogs

            9.3.1.2. Cats

            9.3.1.3. Equine

            9.3.1.4. Others

        9.3.2. Livestock Animals

    9.4. Market Attractiveness Analysis, by Animal Type

10. North America Vet Compounding Pharmacies Market Analysis 2014-2022 and Forecast 2023-2033, By Formulations

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis, By Formulations, 2014-2022

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Formulations, 2023-2033

        10.3.1. Oral

        10.3.2. Injectable

        10.3.3. Others

    10.4. Market Attractiveness Analysis, by Formulations

11. North America Vet Compounding Pharmacies Market Analysis 2014-2022 and Forecast 2023-2033, By Country

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis, by Country, 2014-2022

    11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Country 2023-2033

        11.3.1. U.S.

        11.3.2. Canada

    11.4. Market Attractiveness Analysis, by Country

12. U.S. Vet Compounding Pharmacies Market Analysis 2014-2022 and Forecast 2023-2033

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2014-2022

    12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy, 2023-2033

        12.3.1. By Product

        12.3.2. By Animal Type

        12.3.3. By Formulations

    12.4. Market Attractiveness Analysis

        12.4.1. By Product

        12.4.2. By Animal Type

        12.4.3. By Formulations

13. Canada Vet Compounding Pharmacies Market Analysis 2014-2022 and Forecast 2023-2033

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Trend Analysis, by Market Taxonomy, 2014-2022

    13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, by Market Taxonomy, 2023-2033

        13.3.1. By Product

        13.3.2. By Animal Type

        13.3.3. By Formulations

    13.4. Market Attractiveness Analysis

        13.4.1. By Product

        13.4.2. By Animal Type

        13.4.3. By Formulations

14. Market Structure Analysis

    14.1. Market Analysis, by Tier of Companies

    14.2. Market Share Analysis of Top Players

    14.3. Market Concentration

    14.4. Market Presence Analysis

15. Competition Analysis

    15.1. Competition Dashboard

    15.2. Competition Deep Dive

        15.2.1. Hoye’s Pharmacy

            15.2.1.1. Overview

            15.2.1.2. Product Portfolio

            15.2.1.3. Sales Footprint

            15.2.1.4. Key Financials

            15.2.1.5. SWOT Analysis

            15.2.1.6. Strategy Overview

                15.2.1.6.1. Marketing Strategy

                15.2.1.6.2. Product Strategy

                15.2.1.6.3. Channel Strategy

        15.2.2. Vertisis Custom Pharmacy

            15.2.2.1. Overview

            15.2.2.2. Product Portfolio

            15.2.2.3. Sales Footprint

            15.2.2.4. Key Financials

            15.2.2.5. SWOT Analysis

            15.2.2.6. Strategy Overview

                15.2.2.6.1. Marketing Strategy

                15.2.2.6.2. Product Strategy

                15.2.2.6.3. Channel Strategy

        15.2.3. Smith Caldwell Drug Store

            15.2.3.1. Overview

            15.2.3.2. Product Portfolio

            15.2.3.3. Sales Footprint

            15.2.3.4. Key Financials

            15.2.3.5. SWOT Analysis

            15.2.3.6. Strategy Overview

                15.2.3.6.1. Marketing Strategy

                15.2.3.6.2. Product Strategy

                15.2.3.6.3. Channel Strategy

        15.2.4. Sixth Avenue Medical Pharmacy

            15.2.4.1. Overview

            15.2.4.2. Product Portfolio

            15.2.4.3. Sales Footprint

            15.2.4.4. Key Financials

            15.2.4.5. SWOT Analysis

            15.2.4.6. Strategy Overview

                15.2.4.6.1. Marketing Strategy

                15.2.4.6.2. Product Strategy

                15.2.4.6.3. Channel Strategy

        15.2.5. Dougherty Pharmacy

            15.2.5.1. Overview

            15.2.5.2. Product Portfolio

            15.2.5.3. Sales Footprint

            15.2.5.4. Key Financials

            15.2.5.5. SWOT Analysis

            15.2.5.6. Strategy Overview

                15.2.5.6.1. Marketing Strategy

                15.2.5.6.2. Product Strategy

                15.2.5.6.3. Channel Strategy

        15.2.6. Triangle Compounding Pharmacy Inc.,

            15.2.6.1. Overview

            15.2.6.2. Product Portfolio

            15.2.6.3. Sales Footprint

            15.2.6.4. Key Financials

            15.2.6.5. SWOT Analysis

            15.2.6.6. Strategy Overview

                15.2.6.6.1. Marketing Strategy

                15.2.6.6.2. Product Strategy

                15.2.6.6.3. Channel Strategy

        15.2.7. Wedgewood Pharmacy

            15.2.7.1. Overview

            15.2.7.2. Product Portfolio

            15.2.7.3. Sales Footprint

            15.2.7.4. Key Financials

            15.2.7.5. SWOT Analysis

            15.2.7.6. Strategy Overview

                15.2.7.6.1. Marketing Strategy

                15.2.7.6.2. Product Strategy

                15.2.7.6.3. Channel Strategy

        15.2.8. Millers Pharmacy

            15.2.8.1. Overview

            15.2.8.2. Product Portfolio

            15.2.8.3. Sales Footprint

            15.2.8.4. Key Financials

            15.2.8.5. SWOT Analysis

            15.2.8.6. Strategy Overview

                15.2.8.6.1. Marketing Strategy

                15.2.8.6.2. Product Strategy

                15.2.8.6.3. Channel Strategy

        15.2.9. Chiron Compounding Pharmacy

            15.2.9.1. Overview

            15.2.9.2. Product Portfolio

            15.2.9.3. Sales Footprint

            15.2.9.4. Key Financials

            15.2.9.5. SWOT Analysis

            15.2.9.6. Strategy Overview

                15.2.9.6.1. Marketing Strategy

                15.2.9.6.2. Product Strategy

                15.2.9.6.3. Channel Strategy

        15.2.10. MEDS Canadian Compounding Pharmacy

            15.2.10.1. Overview

            15.2.10.2. Product Portfolio

            15.2.10.3. Sales Footprint

            15.2.10.4. Key Financials

            15.2.10.5. SWOT Analysis

            15.2.10.6. Strategy Overview

                15.2.10.6.1. Marketing Strategy

                15.2.10.6.2. Product Strategy

                15.2.10.6.3. Channel Strategy

        15.2.11. Aurora Compounding

            15.2.11.1. Overview

            15.2.11.2. Product Portfolio

            15.2.11.3. Sales Footprint

            15.2.11.4. Key Financials

            15.2.11.5. SWOT Analysis

            15.2.11.6. Strategy Overview

                15.2.11.6.1. Marketing Strategy

                15.2.11.6.2. Product Strategy

                15.2.11.6.3. Channel Strategy

        15.2.12. Pace Pharmacy

            15.2.12.1. Overview

            15.2.12.2. Product Portfolio

            15.2.12.3. Sales Footprint

            15.2.12.4. Key Financials

            15.2.12.5. SWOT Analysis

            15.2.12.6. Strategy Overview

                15.2.12.6.1. Marketing Strategy

                15.2.12.6.2. Product Strategy

                15.2.12.6.3. Channel Strategy

        15.2.13. Victoria Compounding Pharmacy

            15.2.13.1. Overview

            15.2.13.2. Product Portfolio

            15.2.13.3. Sales Footprint

            15.2.13.4. Key Financials

            15.2.13.5. SWOT Analysis

            15.2.13.6. Strategy Overview

                15.2.13.6.1. Marketing Strategy

                15.2.13.6.2. Product Strategy

                15.2.13.6.3. Channel Strategy

        15.2.14. Pratt’s Compounding Pharmacy

            15.2.14.1. Overview

            15.2.14.2. Product Portfolio

            15.2.14.3. Sales Footprint

            15.2.14.4. Key Financials

            15.2.14.5. SWOT Analysis

            15.2.14.6. Strategy Overview

                15.2.14.6.1. Marketing Strategy

                15.2.14.6.2. Product Strategy

                15.2.14.6.3. Channel Strategy

        15.2.15. People’s Choice Pharmacy

            15.2.15.1. Overview

            15.2.15.2. Product Portfolio

            15.2.15.3. Sales Footprint

            15.2.15.4. Key Financials

            15.2.15.5. SWOT Analysis

            15.2.15.6. Strategy Overview

                15.2.15.6.1. Marketing Strategy

                15.2.15.6.2. Product Strategy

                15.2.15.6.3. Channel Strategy

16. Assumptions and Acronyms Used

17. Research Methodology